We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Fusionex | LSE:FXI | London | Ordinary Share | JE00B8BL8C53 | ORD NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 63.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMFXI
RNS Number : 8595B
Fusionex International PLC
07 April 2017
RNS 7 April 2017
Fusionex International PLC
("Fusionex" or the "Group")
Contract win with multinational healthcare system provider
Fusionex, a leading provider of Analytics and Big Data software, is pleased to announce that it has won a new contract with a major multinational Asian healthcare company for GIANT 2017, its award-winning Big Data platform. The initial contract with the medical supplier is in the region of USD300,000, with the value expected to increase alongside the adoption rate within the client's various departments and at different offices across Asia.
GIANT 2017 will enable the client to gain intelligent e-commerce insights to boost revenues and improve overall system management by the medical professionals across the business through a wide spectrum of data analytics. GIANT 2017 enables administrators to monitor user preferences and needs, as well as identify the preferences of medical professionals whether in terms of equipment, events or reading materials.
The integrated regional medical supplier of equipment, supplies, and services supports a network of thousands of healthcare institutions, including government and private hospitals, surgery centers, specialist and primary care clinics, laboratories, and nursing homes across Asia.
Ivan Teh, Chief Executive Officer of Fusionex, commented:
"This GIANT win further demonstrates the capability and applicability of Big Data Analytics to the healthcare industry, a core focus for Fusionex. We are delighted to enter into the relationship and we know that the insights and benefits that GIANT will bring to medical professionals will ultimately help thousands of patients. The adoption of Big Data in healthcare is crucial and we believe that Fusionex will continue to generate significant revenues from the sector."
For further details:
Fusionex
Ivan Teh, Chief Executive Officer Through Buchanan Yuen Choong Lai, Chief Financial Officer Darren Hopkins, Director of Investor Relations & Corporate Development Stifel Fred Walsh, Neil Shah, Ben Maddison, Rajpal Padam 0207 710 7600 Peel Hunt 0207 418 8900 Richard Kauffer, Euan Brown Buchanan Giles Sanderson, Steph Watson, Patrick Hanrahan 020 7466 5000
This information is provided by RNS
The company news service from the London Stock Exchange
END
CNTUNUNRBAASRAR
(END) Dow Jones Newswires
April 07, 2017 02:00 ET (06:00 GMT)
1 Year Fusionex Chart |
1 Month Fusionex Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions